BioCardia, Inc. (BCDA) has 21 SEC Form 4 insider filings on record in the last 90 days. That includes 9 insider purchases totalling $132K. Most recent filing: Sept. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 4, 2026 filed Sept. 3, 2026 | Altman Peter President and CEO | +$872 | 800 | +0% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Altman Peter President and CEO | +$5,022 | 5,400 | +1% | No | |
|
|
||||||
| Aug. 13, 2026 | Altman Peter President and CEO | +$1,748 | 1,900 | +1% | No | |
|
|
||||||
| July 29, 2026 | Altman Peter President and CEO | +$3,900 | 5,000 | +1% | No | |
|
|
||||||
| July 20, 2026 filed July 17, 2026 | Altman Peter President and CEO | +$415 | 500 | +0% | No | |
|
|
||||||
Showing the 5 most recent of 21 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free